ONCOLOGY Vol 36, Issue 3 | Oncology

Expert Commentary on the Product Profile of Amivantamab-vmjw

March 12, 2022


In an interview with ONCOLOGY®, Evan B. Bryson, PharmD, BCOP, offers a comprehensive review of real-world treatment considerations of amivantamab as therapy for patients with non–small cell lung cancer.

The Emerging Value of ctDNA in Colon Cancer Adjuvant Therapy Decisions

March 10, 2022


In this month’s Letter to the Readers, ONCOLOGY co-editor-in-chief Howard S. Hochster, MD, reviews results of the CIRCULATE-Japan clinical trial that were presented at the 2022 Gastrointestinal Cancers Symposium.